Sort
39,280 grants matching “leukemia”
Next Generation gene discovery in neurogenetics
$505,104Wendy H Raskind · University Of Washington · R01 · FY2018 · NS
MOLECULAR CORRELATES OF HOXB4 FUNCTION
$505,089Bernard G Forget · Yale University · P01 · FY2007 · HL
Project 2 - Preclinical studies: Overcoming tumor heterogeneity
$505,053Steven Mark Albelda · University Of Pennsylvania · P01 · FY2022 · CA
Designing T cells to Functionally Cure HIV-1 infection
$505,007James L Riley · University Of Pennsylvania · U19 · FY2015 · AI
The genomic pathogenesis of Follicular Lymphoma
$504,983Sami Nimer Malek · University Of Michigan At Ann Arbor · R01 · FY2019 · CA
GENETIC EPIDEMIOLOGY OF CHRONIC LYMPHOCYTIC LEUKEMIA
$504,949Nicola J Camp · University Of Utah · R01 · FY2013 · CA
CD45 Pretargeted Radioimmunotherapy for AML
$504,933Fred Hutchinson Cancer Research Center · R01 · FY2004 · CA
Inflammation, Macrophage Differentiation, and Cancer
$504,913Zheng-Gang Liu · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Signal Transduction by Non-transmembrane PTPs
$504,898Benjamin G. Neel · Beth Israel Deaconess Medical Center · R37 · FY2006 · CA
Investigations of menin function in Ewing sarcoma
$504,714Elizabeth R Lawlor · Seattle Children'S Hospital · R01 · FY2022 · CA
Early Immune Development and Function in Neonates Exposed to Maternal HIV Infection
$504,713Huanbin Xu · Tulane University Of Louisiana · R01 · FY2020 · AI
Targeting DNA repair to eradicate TKI-refractory/resistant CML
$504,699Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2017 · CA
Project 2 - Preclinical studies: Overcoming tumor heterogeneity
$504,690Steven Mark Albelda · University Of Pennsylvania · P01 · FY2019 · CA
Stage-specific roles for Zmiz1 in Notch-dependent steps of early T-cell development
$504,685Mark Y Chiang · University Of Michigan At Ann Arbor · R01 · FY2020 · AI
Novel Biomarkers to Risk-Stratify AML Patients with NPM1^Pos/FLT3-IT^Neg Genotype
$504,672Derek L Stirewalt · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA
Metabolic Syndrome in Childhood Cancer Survivors
$504,537Julia Steinberger · University Of Minnesota · R01 · FY2008 · CA
Illuminating molecular targetable pathways in HNSCC
$504,499Molly F. Kulesz-Martin · Oregon Health & Science University · R01 · FY2016 · CA
Illuminating molecular targetable pathways in HNSCC
$504,499Molly F. Kulesz-Martin · Oregon Health & Science University · R01 · FY2018 · CA
Hepatic Gene Transfer for Treatment of Hemophilias A&B
$504,498Stanford University · R01 · FY2005 · HL
CAREER: Development of DNA nanocarriers to redirect immune cells toward chosen targets
$504,492Matthias Stephan · Fred Hutchinson Cancer Research Center · · FY2015 · ENG
CD19 Directed CAR Therapy
$504,482Carl H. June · University Of Pennsylvania · R01 · FY2015 · CA
Clinical Consortia (Pediatric & Adult)
$504,380Stephen E Sallan · Dana-Farber Cancer Inst · P01 · FY2009 · CA
Hematopoiesis in germline RUNX1mutation carriers: impact of inflammation and the bone marrow niche
$504,283Anupriya Agarwal · Oregon Health & Science University · R01 · FY2024 · HL
Mechanisms of resistance to ponatinib therapy in chronic myeloid leukemia
$504,278Thomas J. O'Hare · University Of Utah · R01 · FY2014 · CA
Quantitative protein network profiling to improve CAR design and efficacy
$504,231Stephen Edward Paucha Smith · Seattle Children'S Hospital · R01 · FY2021 · CA